Impact of concomitant corticosteroid use on adverse events in ulcerative colitis clinical trials
Corticosteroid use is independently associated with increased AEs in UC clinical trials. Continued monitoring and strategies for corticosteroid tapering may reduce AE burden.
Authors
- Vipul Jairath (ORCID: https://orcid.org/0000-0001-8603-898X)
- Hasan Hamam (ORCID: https://orcid.org/0009-0000-6999-3125)
- Walter Reinisch (ORCID: https://orcid.org/0000-0002-2088-091X)
- John K. Marshall (ORCID: https://orcid.org/0000-0002-0523-9032)
- Parambir S. Dulai (ORCID: https://orcid.org/0000-0002-9514-2321)
- Neeraj Narula (ORCID: https://orcid.org/0000-0002-1536-8436)
- Christopher Ma (ORCID: https://orcid.org/0000-0002-4698-9948)
Institutions
- Northwestern University (US)
- Western University (CA)
- University of Calgary (CA)
- Population Health Research Institute (CA)
- Northwestern University (PH)
- Institut de Recherche en Santé Digestive (FR)
- Northwestern Medicine (US)
- Medical University of Vienna (AT)
- McMaster University (CA)
Publication Details
- Journal
- Journal of Crohn s and Colitis
- Published
- 2025-08-01
- DOI
- https://doi.org/10.1093/ecco-jcc/jjaf145
- Citations
- 1
- Primary Topic
- Microscopic Colitis
- Type
- article
- Field-Weighted Citation Impact
- 1.35